Erratum to “Nutrition Therapy”(Canadian Journal of Diabetes (2018) 42(S1) (S64–S79)(S1499267117308195)(10.1016/j.jcjd.2017.10.009));Nutrition Therapy

Canadian Journal of Diabetes

Volumn 42, Issue , 2018, Pages S64-S79

  Sievenpiper, John L ^a   Chan, Catherine B ^a   Dworatzek, Paula D ^a   Freeze, Catherine ^a   Williams, Sandra L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACESULFAME; ALCOHOL; ASPARTAME; CARBOHYDRATE; CYCLAMATE SODIUM; ERYTHRITOL; FAT; INSULIN; NEOTAME; PROTEIN; SACCHARIN; SUCRALOSE; SUGAR; TAGATOSE; THAUMATIN;

ARTICLE; CALORIC INTAKE; CARBOHYDRATE INTAKE; CULTURAL DIVERSITY; DAIRY PRODUCT; DASH DIET; DIET; DIET RESTRICTION; DIET THERAPY; DIETARY FIBER; FAT INTAKE; FRUIT; GLYCEMIC INDEX; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LEGUME; LIFESTYLE MODIFICATION; MACRONUTRIENT; MEAL; MEDITERRANEAN DIET; MINERAL SUPPLEMENTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NORDIC DIET; NUT; NUTRITIONAL COUNSELING; PRACTICE GUIDELINE; PROTEIN INTAKE; SODIUM RESTRICTION; SUGAR INTAKE; VEGETABLE; VEGETARIAN DIET; VITAMIN SUPPLEMENTATION; WEIGHT LOSS PROGRAM; WHOLE GRAIN; DIABETES MELLITUS; PROGNOSIS; STANDARDS;

DIABETES MELLITUS; HUMANS; NUTRITION THERAPY; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS;

EID: 85044746464     PISSN: 14992671     EISSN: 23523840     Source Type: Journal    
DOI: 10.1016/j.jcjd.2018.12.003     Document Type: Erratum

References (252)

1. Pastors, J.G., Warshaw, H., Daly, A., et al. The evidence for the effectiveness of medical nutrition therapy in diabetes management. Diabetes Care 25 (2002), 608–613.
2. Pi-Sunyer, F.X., Maggio, C.A., McCarron, D.A., et al. Multicenter randomized trial of a comprehensive prepared meal program in type 2 diabetes. Diabetes Care 22 (1999), 191–197.
3. Franz, M.J., Monk, A., Barry, B., et al. Effectiveness of medical nutrition therapy provided by dietitians in the management of non-insulin-dependent diabetes mellitus: A randomized, controlled clinical trial. J Am Diet Assoc 95 (1995), 1009–1017.
4. Kulkarni, K., Castle, G., Gregory, R., et al. Nutrition practice guidelines for type 1 diabetes mellitus positively affect dietitian practices and patient outcomes. The Diabetes Care and Education Dietetic Practice Group. J Am Diet Assoc 98 (1998), 62–70 quiz 1-2.
5. Gaetke, L.M., Stuart, M.A., Truszczynska, H., A single nutrition counseling session with a registered dietitian improves short-term clinical outcomes for rural Kentucky patients with chronic diseases. J Am Diet Assoc 106 (2006), 109–112.
6. Imai, S., Kozai, H., Matsuda, M., et al. Intervention with delivery of diabetic meals improves glycemic control in patients with type 2 diabetes mellitus. J Clin Biochem Nutr 42 (2008), 59–63.
7. Huang, M.C., Hsu, C.C., Wang, H.S., et al. Prospective randomized controlled trial to evaluate effectiveness of registered dietitian-led diabetes management on glycemic and diet control in a primary care setting in Taiwan. Diabetes Care 33 (2010), 233–239.
8. Robbins, J.M., Thatcher, G.E., Webb, D.A., et al. Nutritionist visits, diabetes classes, and hospitalization rates and charges: The Urban Diabetes Study. Diabetes Care 31 (2008), 655–660.
9. StatsCan, Immigration and ethnocultural diversity in Canada. 2011, Statistics Canada, Ottawa Report No.: Catalogue no. 99-010-X2011001 http://www12.statcan.gc.ca/nhs-enm/2011/as-sa/99-010-x/99-010-x2011001-eng.pdf.
10. Gougeon, R., Sievenpiper, J.L., Jenkins, D., et al. The transcultural diabetes nutrition algorithm: A Canadian perspective. Int J Endocrinol, 2014, 2014, 151068.
11. Norris, S.L., Engelgau, M.M., Narayan, K.M., Effectiveness of self-management training in type 2 diabetes: A systematic review of randomized controlled trials. Diabetes Care 24 (2001), 561–587.
12. Ash, S., Reeves, M.M., Yeo, S., et al. Effect of intensive dietetic interventions on weight and glycaemic control in overweight men with Type II diabetes: A randomised trial. Int J Obes Relat Metab Disord 27 (2003), 797–802.
13. Vallis, T.M., Higgins-Bowser, I., Edwards, L., The role of diabetes education in maintaining lifestyle changes. Can J Diabetes 29 (2005), 193–202.
14. Willaing, I., Ladelund, S., Jorgensen, T., et al. Nutritional counselling in primary health care: A randomized comparison of an intervention by general practitioner or dietician. Eur J Cardiovasc Prev Rehabil 11 (2004), 513–520.
15. Wilson, C., Brown, T., Acton, K., et al. Effects of clinical nutrition education and educator discipline on glycemic control outcomes in the Indian health service. Diabetes Care 26 (2003), 2500–2504.
16. Brekke, H.K., Jansson, P.A., Lenner, R.A., Long-term (1- and 2-year) effects of lifestyle intervention in type 2 diabetes relatives. Diabetes Res Clin Pract 70 (2005), 225–234.
17. Lemon, C.C., Lacey, K., Lohse, B., et al. Outcomes monitoring of health, behavior, and quality of life after nutrition intervention in adults with type 2 diabetes. J Am Diet Assoc 104 (2004), 1805–1815.
18. Rickheim, P.L., Weaver, T.W., Flader, J.L., et al. Assessment of group versus individual diabetes education: A randomized study. Diabetes Care 25 (2002), 269–274.
19. Trento, M., Basile, M., Borgo, E., et al. A randomised controlled clinical trial of nurse-, dietitian- and pedagogist-led group care for the management of type 2 diabetes. J Endocrinol Invest 31 (2008), 1038–1042.
20. Pérez-Escamilla, R., Hromi-Fiedler, A., Vega-López, S., et al. Impact of peer nutrition education on dietary behaviors and health outcomes among Latinos: A systematic literature review. J Nutr Educ Behav 40 (2008), 208–225.
21. Ralston, J.D., Hirsch, I.B., Hoath, J., et al. Web-based collaborative care for type 2 diabetes: A pilot randomized trial. Diabetes Care 32 (2009), 234–239.
22. Marcy, T.R., Britton, M.L., Harrison, D., Identification of barriers to appropriate dietary behavior in low-income patients with type 2 diabetes mellitus. Diabetes Ther 2 (2011), 9–19.
23. Christensen, N.K., Terry, R.D., Wyatt, S., et al. Quantitative assessment of dietary adherence in patients with insulin-dependent diabetes mellitus. Diabetes Care 6 (1983), 245–250.
24. Toeller, M., Klischan, A., Heitkamp, G., et al. Nutritional intake of 2868 IDDM patients from 30 centres in Europe. EURODIAB IDDM Complications Study Group. Diabetologia 39 (1996), 929–939.
25. Glazier, R.H., Bajcar, J., Kennie, N.R., et al. A systematic review of interventions to improve diabetes care in socially disadvantaged populations. Diabetes Care 29 (2006), 1675–1688.
26. Anderson, T.J., Grégoire, J., Pearson, G.J., et al. 2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol 32 (2016), 1263–1282.
27. Wing, R.R., Weight loss in the management of type 2 diabetes. Gerstein, H.C., Haynes, B., (eds.) Evidence-based diabetes, 2000, B.C, Decker Inc., Ontario.
28. Tuomilehto, J., Lindström, J., Eriksson, J.G., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344 (2001), 1343–1350.
29. Knowler, W.C., Barrett-Connor, E., Fowler, S.E., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346 (2002), 393–403.
30. The Look Ahead Research Group, Wing, R.R., Long term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes: Four year results of the Look AHEAD trial. Arch Intern Med 170 (2010), 1566–1575.
31. Food and Nutrition Board, Institute of Medicine of the National Academics, Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. 2005, The National Academies Press, Washington https://www.nal.usda.gov/sites/default/files/fnic_uploads//energy_full_report.pdf.
32. Barnard, N.D., Cohen, J., Jenkins, D.J., et al. A low-fat vegan diet improves glycemic control and cardiovascular risk factors in a randomized clinical trial in individuals with type 2 diabetes. Diabetes Care 29 (2006), 1777–1783.
33. Kirk, J.K., Graves, D.E., Craven, T.E., et al. Restricted-carbohydrate diets in patients with type 2 diabetes: A meta-analysis. J Am Diet Assoc 108 (2008), 91–100.
34. Dyson, P., Low carbohydrate diets and type 2 diabetes: What is the latest evidence?. Diabetes Ther 6 (2015), 411–424.
35. van Wyk, H.J., Davis, R.E., Davies, J.S., A critical review of low-carbohydrate diets in people with type 2 diabetes. Diabet Med 33 (2016), 148–157.
36. Johnston, B.C., Kanters, S., Bandayrel, K., et al. Comparison of weight loss among named diet programs in overweight and obese adults: A meta-analysis. JAMA 312 (2014), 923–933.
37. Yabe, D., Iwasaki, M., Kuwata, H., et al. Sodium-glucose co-transporter-2 inhibitor use and dietary carbohydrate intake in Japanese individuals with type 2 diabetes: A randomized, open-label, 3-arm parallel comparative, exploratory study. Diabetes Obes Metab 19 (2016), 739–743.
38. Krebs, J.D., Parry Strong, A., Cresswell, P., et al. A randomised trial of the feasibility of a low carbohydrate diet vs standard carbohydrate counting in adults with type 1 diabetes taking body weight into account. Asia Pac J Clin Nutr 25 (2016), 78–84.
39. Nielsen, J.V., Gando, C., Joensson, E., et al. Low carbohydrate diet in type 1 diabetes, long-term improvement and adherence: A clinical audit. Diabetol Metab Syndr, 4, 2012, 23.
40. Ranjan, A., Schmidt, S., Damm-Frydenberg, C., et al. Low-carbohydrate diet impairs the effect of glucagon in the treatment of insulin-induced mild hypoglycemia: A randomized crossover study. Diabetes Care 40 (2017), 132–135.
41. Ranjan, A., Schmidt, S., Madsbad, S., et al. Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes. Diabetes Obes Metab 18 (2016), 410–418.
42. Jenkins, D.J., Wolever, T.M., Taylor, R.H., et al. Glycemic index of foods: A physiological basis for carbohydrate exchange. Am J Clin Nutr 34 (1981), 362–366.
43. Atkinson, F.S., Foster-Powell, K., Brand-Miller, J.C., International tables of glycemic index and glycemic load values: 2008. Diabetes Care 31 (2008), 2281–2283.
44. Jenkins, D.J., Kendall, C.W., McKeown-Eyssen, G., et al. Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes: A randomized trial. JAMA 300 (2008), 2742–2753.
45. Brand-Miller, J., Hayne, S., Petocz, P., et al. Low-glycemic index diets in the management of diabetes: A meta-analysis of randomized controlled trials. Diabetes Care 26 (2003), 2261–2267.
46. Opperman, A.M., Venter, C.S., Oosthuizen, W., et al. Meta-analysis of the health effects of using the glycaemic index in meal-planning. Br J Nutr 92 (2004), 367–381.
47. Thomas, D.E., Elliott, E.J., The use of low-glycaemic index diets in diabetes control. Br J Nutr 104 (2010), 797–802.
48. Wolever, T.M., Gibbs, A.L., Mehling, C., et al. The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: No effect on glycated hemoglobin but reduction in C-reactive protein. Am J Clin Nutr 87 (2008), 114–125.
49. Goff, L.M., Cowland, D.E., Hooper, L., et al. Low glycaemic index diets and blood lipids: A systematic review and meta-analysis of randomised controlled trials. Nutr Metab Cardiovasc Dis 23 (2013), 1–10.
50. Ajala, O., English, P., Pinkney, J., Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr 97 (2013), 505–516.
51. Wang, Q., Xia, W., Zhao, Z., et al. Effects comparison between low glycemic index diets and high glycemic index diets on HbA1c and fructosamine for patients with diabetes: A systematic review and meta-analysis. Prim Care Diabetes 9 (2015), 362–369.
52. Mirrahimi, A., de Souza, R.J., Chiavaroli, L., et al. Associations of glycemic index and load with coronary heart disease events: A systematic review and meta-analysis of prospective cohorts. J Am Heart Assoc, 1, 2012, e000752.
53. Policy for labelling and advertising of dietary fibre-containing food products, 2012, Bureau of Nutritional Sciences Food Directorate, Health Products and Food Branch: Health Canada, Ottawa http://www.hc-sc.gc.ca/fn-an/alt_formats/pdf/legislation/pol/fibre-label-etiquetage-eng.pdf.
54. Anderson, J.W., Randles, K.M., Kendall, C.W., et al. Carbohydrate and fiber recommendations for individuals with diabetes: A quantitative assessment and meta-analysis of the evidence. J Am Coll Nutr 23 (2004), 5–17.
55. Grundy, M.M., Edwards, C.H., Mackie, A.R., et al. Re-evaluation of the mechanisms of dietary fibre and implications for macronutrient bioaccessibility, digestion and postprandial metabolism. Br J Nutr 116 (2016), 816–833.
56. Vuksan, V., Jenkins, D.J., Spadafora, P., et al. Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial. Diabetes Care 22 (1999), 913–919.
57. Tiwari, U., Cummins, E., Meta-analysis of the effect of beta-glucan intake on blood cholesterol and glucose levels. Nutrition 27 (2011), 1008–1016.
58. Post, R.E., Mainous, A.G. 3rd, King, D.E., et al. Dietary fiber for the treatment of type 2 diabetes mellitus: A meta-analysis. J Am Board Fam Med 25 (2012), 16–23.
59. Brown, L., Rosner, B., Willett, W.W., et al. Cholesterol-lowering effects of dietary fiber: A meta-analysis. Am J Clin Nutr 69 (1999), 30–42.
60. Ho, H.V., Sievenpiper, J.L., Zurbau, A., et al. A systematic review and meta-analysis of randomized controlled trials of the effect of barley beta-glucan on LDL-C, non-HDL-C and apoB for cardiovascular disease risk reductioni-iv. Eur J Clin Nutr 70 (2016), 1239–1245.
61. Ho, H.V., Sievenpiper, J.L., Zurbau, A., et al. The effect of oat beta-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: A systematic review and meta-analysis of randomised-controlled trials. Br J Nutr 116 (2016), 1369–1382.
62. Summary of Health Canada's assessment of a health claim about food products containing psyllium an dblood cholesterol lowering, 2011, Bureau of Nutritional Sciences Food Directorate, Health Products and Food Branch: Health Canada, Ottawa http://www.hc-sc.gc.ca/fn-an/alt_formats/pdf/label-etiquet/claims-reclam/assess-evalu/psyllium-cholesterol-eng.pdf.
63. Summary of Health Canada's assessment of a health claim about barley products and blood cholesterol lowering, 2012, Bureau of Nutritional Sciences Food Directorate, Health Products and Food Branch: Health Canada, Ottawa http://www.hc-sc.gc.ca/fn-an/alt_formats/pdf/label-etiquet/claims-reclam/assess-evalu/barley-orge-eng.pdf.
64. Oat products and blood cholesterol lowering. Summary of assessment of a health claim about oat products and blood cholesterol lowering, 2010, Bureau of Nutritional Sciences Food Directorate, Health Products and Food Branch: Health Canada, Ottawa http://www.hc-sc.gc.ca/fn-an/alt_formats/pdf/label-etiquet/claims-reclam/assess-evalu/oat_avoine-eng.pdf.
65. Vuksan, V., Jenkins, A.L., Jenkins, D.J., et al. Using cereal to increase dietary fiber intake to the recommended level and the effect of fiber on bowel function in healthy persons consuming North American diets. Am J Clin Nutr 88 (2008), 1256–1262.
66. Jenkins, D.J., Kendall, C.W., Augustin, L.S., et al. Effect of wheat bran on glycemic control and risk factors for cardiovascular disease in type 2 diabetes. Diabetes Care 25 (2002), 1522–1528.
67. Jenkins, D.J., Kendall, C.W., Augustin, L.S., et al. Effect of legumes as part of a low glycemic index diet on glycemic control and cardiovascular risk factors in type 2 diabetes mellitus: A randomized controlled trial. Arch Intern Med 172 (2012), 1653–1660.
68. Schoenaker, D.A., Toeller, M., Chaturvedi, N., et al. Dietary saturated fat and fibre and risk of cardiovascular disease and all-cause mortality among type 1 diabetic patients: The EURODIAB Prospective Complications Study. Diabetologia 55 (2012), 2132–2141.
69. Threapleton, D.E., Greenwood, D.C., Evans, C.E.L., et al. Dietary fibre intake and risk of cardiovascular disease: Systematic review and meta-analysis. BMJ, 347, 2013, f6879.
70. Chandalia, M., Garg, A., Lutjohann, D., et al. Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus. N Engl J Med 342 (2000), 1392–1398.
71. Te Morenga, L.A., Howatson, A.J., Jones, R.M., et al. Dietary sugars and cardiometabolic risk: Systematic review and meta-analyses of randomized controlled trials of the effects on blood pressure and lipids. Am J Clin Nutr 100 (2014), 65–79.
72. Te Morenga, L., Mallard, S., Mann, J., Dietary sugars and body weight: Systematic review and meta-analyses of randomised controlled trials and cohort studies. BMJ, 346, 2013, e7492.
73. Choo, V.L., Cozma, A.I., Viguiliouk, E., et al. The effect of fructose-containing sugars on glycemic control: A systematic review and meta-analysis of controlled trials. FASEB J, 30, 2016, 685.5.
74. Sievenpiper, J.L., de Souza, R.J., Mirrahimi, A., et al. Effect of fructose on body weight in controlled feeding trials: A systematic review and meta-analysis. Ann Intern Med 156 (2012), 291–304.
75. Sievenpiper, J.L., Chiavaroli, L., de Souza, R.J., et al. “Catalytic” doses of fructose may benefit glycaemic control without harming cardiometabolic risk factors: A small meta-analysis of randomised controlled feeding trials. Br J Nutr 108 (2012), 418–423.
76. Ha, V., Sievenpiper, J.L., De Souza, R.J., et al. Effect of fructose on blood pressure: A systematic review and meta-analysis of controlled feeding trials. Hypertension 59 (2012), 787–795.
77. Sievenpiper, J.L., Carleton, A.J., Chatha, S., et al. Heterogeneous effects of fructose on blood lipids in individuals with type 2 diabetes: Systematic review and meta-analysis of experimental trials in humans. Diabetes Care 32 (2009), 1930–1937.
78. Chiavaroli, L., de Souza, R.J., Ha, V., et al. Effect of fructose on established lipid targets: A systematic review and meta-analysis of controlled feeding trials. J Am Heart Assoc, 4, 2015, e001700.
79. Wang, X., Ouyang, Y., Liu, J., et al. Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: Systematic review and dose-response meta-analysis of prospective cohort studies. BMJ, 349, 2014, g4490.
80. Chiu, S., Sievenpiper, J.L., de Souza, R.J., et al. Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials. Eur J Clin Nutr 68 (2014), 416–423.
81. Wang, D.D., Sievenpiper, J.L., de Souza, R.J., et al. The effects of fructose intake on serum uric acid vary among controlled dietary trials. J Nutr 142 (2012), 916–923.
82. Cozma, A.I., Sievenpiper, J.L., de Souza, R.J., et al. Effect of fructose on glycemic control in diabetes: A systematic review and meta-analysis of controlled feeding trials. Diabetes Care 35 (2012), 1611–1620.
83. Livesey, G., Taylor, R., Fructose consumption and consequences for glycation, plasma triacylglycerol, and body weight: Meta-analyses and meta-regression models of intervention studies. Am J Clin Nutr 88 (2008), 1419–1437.
84. Lowndes, J., Kawiecki, D., Pardo, S., et al. The effects of four hypocaloric diets containing different levels of sucrose or high fructose corn syrup on weight loss and related parameters. Nutr J, 11, 2012, 55.
85. Bravo, S., Lowndes, J., Sinnett, S., et al. Consumption of sucrose and high-fructose corn syrup does not increase liver fat or ectopic fat deposition in muscles. Appl Physiol Nutr Metab 38 (2013), 681–688.
86. Lowndes, J., Sinnett, S., Pardo, S., et al. The effect of normally consumed amounts of sucrose or high fructose corn syrup on lipid profiles, body composition and related parameters in overweight/obese subjects. Nutrients 6 (2014), 1128–1144.
87. Lowndes, J., Sinnett, S., Yu, Z., et al. The effects of fructose-containing sugars on weight, body composition and cardiometabolic risk factors when consumed at up to the 90th percentile population consumption level for fructose. Nutrients 6 (2014), 3153–3168.
88. Xi, B., Huang, Y., Reilly, K.H., et al. Sugar-sweetened beverages and risk of hypertension and CVD: A dose-response meta-analysis. Br J Nutr 113 (2015), 709–717.
89. Jayalath, V.H., de Souza, R.J., Ha, V., et al. Sugar-sweetened beverage consumption and incident hypertension: A systematic review and meta-analysis of prospective cohorts. Am J Clin Nutr 102 (2015), 914–921.
90. Jayalath, V.H., Sievenpiper, J.L., de Souza, R.J., et al. Total fructose intake and risk of hypertension: A systematic review and meta-analysis of prospective cohorts. J Am Coll Nutr 33 (2014), 328–339.
91. Tasevska, N., Park, Y., Jiao, L., et al. Sugars and risk of mortality in the NIH-AARP Diet and Health Study. Am J Clin Nutr 99 (2014), 1077–1088.
92. Liu, S., Willett, W.C., Stampfer, M.J., et al. A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. Am J Clin Nutr 71 (2000), 1455–1461.
93. Beulens, J.W., de Bruijne, L.M., Stolk, R.P., et al. High dietary glycemic load and glycemic index increase risk of cardiovascular disease among middle-aged women: A population-based follow-up study. J Am Coll Cardiol 50 (2007), 14–21.
94. Sieri, S., Krogh, V., Berrino, F., et al. Dietary glycemic load and index and risk of coronary heart disease in a large italian cohort: The EPICOR study. Arch Intern Med 170 (2010), 640–647.
95. Burger, K.N., Beulens, J.W., Boer, J.M., et al. Dietary glycemic load and glycemic index and risk of coronary heart disease and stroke in Dutch men and women: The EPIC-MORGEN study. PLoS ONE, 6, 2011, e25955.
96. Burger, K.N., Beulens, J.W., van der Schouw, Y.T., et al. Dietary fiber, carbohydrate quality and quantity, and mortality risk of individuals with diabetes mellitus. PLoS ONE, 7, 2012, e43127.
97. Tsilas, C.S., de Souza, R.J., Mejia, S.B., et al. Relation of total sugars, fructose and sucrose with incident type 2 diabetes: a systematic review and meta-analysis of prospective cohort studies. CMAJ 189:20 (2017), E711–E720, 10.1503/cmaj.160706.
98. Mozaffarian, D., Hao, T., Rimm, E.B., et al. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med 364 (2011), 2392–2404.
99. Tang, G., Wang, D., Long, J., et al. Meta-analysis of the association between whole grain intake and coronary heart disease risk. Am J Cardiol 115 (2015), 625–629.
100. Qin, L.Q., Xu, J.Y., Han, S.F., et al. Dairy consumption and risk of cardiovascular disease: An updated meta-analysis of prospective cohort studies. Asia Pac J Clin Nutr 24 (2015), 90–100.
101. Smith, J.D., Hou, T., Ludwig, D.S., et al. Changes in intake of protein foods, carbohydrate amount and quality, and long-term weight change: Results from 3 prospective cohorts. Am J Clin Nutr 101 (2015), 1216–1224.
102. Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults, Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285 (2001), 2486–2497.
103. Yu-Poth, S., Zhao, G., Etherton, T., et al. Effects of the National Cholesterol Education Program's Step I and Step II dietary intervention programs on cardiovascular disease risk factors: A meta-analysis. Am J Clin Nutr 69 (1999), 632–646.
104. de Souza, R.J., Mente, A., Maroleanu, A., et al. Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: Systematic review and meta-analysis of observational studies. BMJ, 351, 2015, h3978.
105. Hooper, L., Martin, N., Abdelhamid, A., et al. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database Syst Rev(6), 2015 CD011737.
106. Ramsden, C.E., Zamora, D., Leelarthaepin, B., et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: Evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ, 346, 2013, e8707.
107. Li, Y., Hruby, A., Bernstein, A.M., et al. Saturated fats compared with unsaturated fats and sources of carbohydrates in relation to risk of coronary heart disease: A prospective cohort study. J Am Coll Cardiol 66 (2015), 1538–1548.
108. Jakobsen, M.U., Dethlefsen, C., Joensen, A.M., et al. Intake of carbohydrates compared with intake of saturated fatty acids and risk of myocardial infarction: Importance of the glycemic index. Am J Clin Nutr 91 (2010), 1764–1768.
109. de Oliveira Otto, M.C., Mozaffarian, D., Kromhout, D., et al. Dietary intake of saturated fat by food source and incident cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis. Am J Clin Nutr 96 (2012), 397–404.
110. McEwen, B., Morel-Kopp, M.C., Tofler, G., et al. Effect of omega-3 fish oil on cardiovascular risk in diabetes. Diabetes Educ 36 (2010), 565–584.
111. Kromhout, D., Giltay, E.J., Geleijnse, J.M., et al. n–3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 363 (2010), 2015–2026.
112. The ORIGIN Trial Investigators, Bosch, J., Gerstein, H.C., et al. n–3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med 367 (2012), 309–318.
113. Rizos, E.C., Ntzani, E.E., Bika, E., et al. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: A systematic review and meta-analysis. JAMA 308 (2012), 1024–1033.
114. Chowdhury, R., Warnakula, S., Kunutsor, S., et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: A systematic review and meta-analysis. Ann Intern Med 160 (2014), 398–406 Erratum in: Ann Intern Med 2014;160:658.
115. Hu, F.B., Cho, E., Rexrode, K.M., et al. Fish and long-chain omega-3 fatty acid intake and risk of coronary heart disease and total mortality in diabetic women. Circulation 107 (2003), 1852–1857.
116. Sala-Vila, A., Díaz-López, A., Valls-Pedret, C., et al. Dietary marine ω-3 fatty acids and incident sight-threatening retinopathy in middle-aged and older individuals with type 2 diabetes: Prospective investigation from the PREDIMED trial. JAMA Ophthalmol 134 (2016), 1142–1149.
117. Lee, C.C., Sharp, S.J., Wexler, D.J., et al. Dietary intake of eicosapentaenoic and docosahexaenoic acid and diabetic nephropathy: Cohort analysis of the diabetes control and complications trial. Diabetes Care 33 (2010), 1454–1456.
118. Hamdy, O., Horton, E.S., Protein content in diabetes nutrition plan. Curr Diab Rep 11 (2011), 111–119.
119. Viguiliouk, E., Stewart, S.E., Jayalath, V.H., et al. Effect of replacing animal protein with plant protein on glycemic control in diabetes: A systematic review and meta-analysis of randomized controlled trials. Nutrients 7 (2015), 9804–9824.
120. Hansen, H.P., Tauber-Lassen, E., Jensen, B.R., et al. Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney Int 62 (2002), 220–228.
121. Pan, Y., Guo, L.L., Jin, H.M., Low-protein diet for diabetic nephropathy: A meta-analysis of randomized controlled trials. Am J Clin Nutr 88 (2008), 660–666.
122. Brodsky, I.G., Robbins, D.C., Hiser, E., et al. Effects of low-protein diets on protein metabolism in insulin-dependent diabetes mellitus patients with early nephropathy. J Clin Endocrinol Metab 75 (1992), 351–357.
123. Qian, F., Korat, A.A., Malik, V., et al. Metabolic effects of monounsaturated fatty acid-enriched diets compared with carbohydrate or polyunsaturated fatty acid-enriched diets in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials. Diabetes Care 39 (2016), 1448–1457.
124. Jenkins, D.J., Kendall, C.W., Vuksan, V., et al. Effect of lowering the glycemic load with canola oil on glycemic control and cardiovascular risk factors: A randomized controlled trial. Diabetes Care 37 (2014), 1806–1814.
125. Kodama, S., Saito, K., Tanaka, S., et al. Influence of fat and carbohydrate proportions on the metabolic profile in patients with type 2 diabetes: A meta-analysis. Diabetes Care 32 (2009), 959–965.
126. Brinkworth, G.D., Noakes, M., Parker, B., et al. Long-term effects of advice to consume a high-protein, low-fat diet, rather than a conventional weight-loss diet, in obese adults with type 2 diabetes: One-year follow-up of a randomised trial. Diabetologia 47 (2004), 1677–1686.
127. Larsen, R.N., Mann, N.J., Maclean, E., et al. The effect of high-protein, low-carbohydrate diets in the treatment of type 2 diabetes: A 12 month randomised controlled trial. Diabetologia 54 (2011), 731–740.
128. Haimoto, H., Iwata, M., Wakai, K., et al. Long-term effects of a diet loosely restricting carbohydrates on HbA1c levels, BMI and tapering of sulfonylureas in type 2 diabetes: A 2-year follow-up study. Diabetes Res Clin Pract 79 (2008), 350–356.
129. Davis, N.J., Tomuta, N., Schechter, C., et al. Comparative study of the effects of a 1-year dietary intervention of a low-carbohydrate diet versus a low-fat diet on weight and glycemic control in type 2 diabetes. Diabetes Care 32 (2009), 1147–1152.
130. Gong, Q., Gregg, E.W., Wang, J., et al. Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: The China Da Qing Diabetes Prevention Outcome Study. Diabetologia 54 (2011), 300–307.
131. Li, G., Zhang, P., Wang, J., et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: A 23-year follow-up study. Lancet Diabetes Endocrinol 2 (2014), 474–480.
132. Wing, R.R., Bolin, P., Brancati, F.L., et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 369 (2013), 145–154.
133. Prior, A.M., Thapa, M., Hua, D.H., Aldose reductase inhibitors and nanodelivery of diabetic therapeutics. Mini Rev Med Chem 12 (2012), 326–336.
134. Mann, J.I., De Leeuw, I., Hermansen, K., et al. Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr Metab Cardiovasc Dis 14 (2004), 373–394.
135. Coppell, K.J., Kataoka, M., Williams, S.M., et al. Nutritional intervention in patients with type 2 diabetes who are hyperglycaemic despite optimised drug treatment—Lifestyle Over and Above Drugs in Diabetes (LOADD) study: Randomised controlled trial. BMJ, 341, 2010, c3337.
136. Willett, W.C., Sacks, F., Trichopoulou, A., et al. Mediterranean diet pyramid: A cultural model for healthy eating. Am J Clin Nutr 61 (1995), 1402s–1406s.
137. Trichopoulou, A., Costacou, T., Bamia, C., et al. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 348 (2003), 2599–2608.
138. Carter, P., Achana, F., Troughton, J., et al. A Mediterranean diet improves HbA1c but not fasting blood glucose compared to alternative dietary strategies: A network meta-analysis. J Hum Nutr Diet 27 (2014), 280–297.
139. Esposito, K., Maiorino, M.I., Ceriello, A., et al. Prevention and control of type 2 diabetes by Mediterranean diet: A systematic review. Diabetes Res Clin Pract 89 (2010), 97–102.
140. Sleiman, D., Al-Badri, M.R., Azar, S.T., Effect of Mediterranean diet in diabetes control and cardiovascular risk modification: A systematic review. Front Public Health, 3, 2015, 69.
141. Esposito, K., Maiorino, M.I., Petrizzo, M., et al. The effects of a Mediterranean diet on the need for diabetes drugs and remission of newly diagnosed type 2 diabetes: Follow-up of a randomized trial. Diabetes Care 37 (2014), 1824–1830.
142. Elhayany, A., Lustman, A., Abel, R., et al. A low carbohydrate Mediterranean diet improves cardiovascular risk factors and diabetes control among overweight patients with type 2 diabetes mellitus: A 1-year prospective randomized intervention study. Diabetes Obes Metab 12 (2010), 204–209.
143. Estruch, R., Ros, E., Salas-Salvadó J., et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 368 (2013), 1279–1290.
144. Díaz-López, A., Babio, N., Martínez-González, M.A., et al. Mediterranean diet, retinopathy, nephropathy, and microvascular diabetes complications: A post hoc analysis of a randomized trial. Diabetes Care 38 (2015), 2134–2141.
145. Barnard, N.D., Cohen, J., Jenkins, D.J., et al. A low-fat vegan diet and a conventional diabetes diet in the treatment of type 2 diabetes: A randomized, controlled, 74-wk clinical trial. Am J Clin Nutr 89 (2009), 1588s–1596s.
146. Yokoyama, Y., Barnard, N.D., Levin, S.M., et al. Vegetarian diets and glycemic control in diabetes: A systematic review and meta-analysis. Cardiovasc Diagn Ther 4 (2014), 373–382.
147. Viguiliouk, E., Kahleová H., Rahelić D., Vegetarian diets improve glycemic control in diabetes: A systematic review and meta-analysis of randomized controlled trials. editors; Proceedings of the 34th international symposium on diabetes and nutrition. Prague: Czech Republic, 2016.
148. Barnard, N.D., Levin, S.M., Yokoyama, Y., A systematic review and meta-analysis of changes in body weight in clinical trials of vegetarian diets. J Acad Nutr Diet 115 (2015), 954–969.
149. Wang, F., Zheng, J., Yang, B., et al. Effects of vegetarian diets on blood lipids: A systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc, 4, 2015, e002408.
150. Jenkins, D.J., Wong, J.M., Kendall, C.W., et al. The effect of a plant-based low-carbohydrate (“Eco-Atkins”) diet on body weight and blood lipid concentrations in hyperlipidemic subjects. Arch Intern Med 169 (2009), 1046–1054.
151. Jenkins, D.J.A., Wong, J.M.W., Kendall, C.W.C., et al. Effect of a 6-month vegan low-carbohydrate (“Eco-Atkins”) diet on cardiovascular risk factors and body weight in hyperlipidaemic adults: A randomised controlled trial. BMJ Open, 4, 2014, 003505.
152. Dinu, M., Abbate, R., Gensini, G.F., et al. Vegetarian, vegan diets and multiple health outcomes: A systematic review with meta-analysis of observational studies. Crit Rev Food Sci Nutr, 2016 (in press).
153. Food and Nutrition Board, Institute of Medicine, Dietary reference intakes for water, potassium, sodium, chloride, and sulfate. 2005, The National Academies Press, Washington https://www.nal.usda.gov/sites/default/files/fnic_uploads//water_full_report.pdf.
154. Thomas, M.C., Moran, J., Forsblom, C., et al. The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care 34 (2011), 861–866.
155. Ekinci, E.I., Clarke, S., Thomas, M.C., et al. Dietary salt intake and mortality in patients with type 2 diabetes. Diabetes Care 34 (2011), 703–709.
156. Appel, L.J., Moore, T.J., Obarzanek, E., et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 336 (1997), 1117–1124.
157. Sacks, F.M., Svetkey, L.P., Vollmer, W.M., et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 344 (2001), 3–10.
158. Siervo, M., Lara, J., Chowdhury, S., et al. Effects of the dietary approach to stop hypertension (DASH) diet on cardiovascular risk factors: A systematic review and meta-analysis. Br J Nutr 113 (2015), 1–15.
159. Azadbakht, L., Fard, N.R., Karimi, M., et al. Effects of the Dietary Approaches to Stop Hypertension (DASH) eating plan on cardiovascular risks among type 2 diabetic patients: A randomized crossover clinical trial. Diabetes Care 34 (2011), 55–57.
160. Azadbakht, L., Surkan, P.J., Esmaillzadeh, A., et al. The dietary approaches to stop hypertension eating plan affects C-reactiabnormalitiesve protein, coagulation, and hepatic function tests among type 2 diabetic patients. J Nutr 141 (2011), 1083–1088.
161. Schwingshackl, L., Hoffmann, G., Diet quality as assessed by the Healthy Eating Index, the Alternate Healthy Eating Index, the Dietary Approaches to Stop Hypertension score, and health outcomes: A systematic review and meta-analysis of cohort studies. J Acad Nutr Diet 115 (2015), 780–800 e5.
162. Jenkins, D.J., Kendall, C.W., Marchie, A., et al. Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA 290 (2003), 502–510.
163. Jenkins, D.J., Jones, P.J., Lamarche, B., et al. Effect of a dietary portfolio of cholesterol-lowering foods given at 2 levels of intensity of dietary advice on serum lipids in hyperlipidemia: A randomized controlled trial. JAMA 306 (2011), 831–839.
164. Lovejoy, J.C., Most, M.M., Lefevre, M., et al. Effect of diets enriched in almonds on insulin action and serum lipids in adults with normal glucose tolerance or type 2 diabetes. Am J Clin Nutr 76 (2002), 1000–1006.
165. Jenkins, D.J., Mirrahimi, A., Srichaikul, K., et al. Soy protein reduces serum cholesterol by both intrinsic and food displacement mechanisms. J Nutr 140 (2010), 2302s–2311s.
166. Tokede, O.A., Onabanjo, T.A., Yansane, A., et al. Soya products and serum lipids: A meta-analysis of randomised controlled trials. Br J Nutr 114 (2015), 831–843.
167. Ras, R.T., Geleijnse, J.M., Trautwein, E.A., LDL-cholesterol-lowering effect of plant sterols and stanols across different dose ranges: A meta-analysis of randomised controlled studies. Br J Nutr 112 (2014), 214–219.
168. Nordic Council, Nordic nutrition recommendations 2004: integrating nutrition and physical acitivity. 4th edn, 2005, Nordic Council of Ministers, Arhus, Denmark.
169. Adamsson, V., Reumark, A., Fredriksson, I.B., et al. Effects of a healthy Nordic diet on cardiovascular risk factors in hypercholesterolaemic subjects: A randomized controlled trial (NORDIET). J Intern Med 269 (2011), 150–159.
170. Uusitupa, M., Hermansen, K., Savolainen, M.J., et al. Effects of an isocaloric healthy Nordic diet on insulin sensitivity, lipid profile and inflammation markers in metabolic syndrome – a randomized study (SYSDIET). J Intern Med 274 (2013), 52–66.
171. Poulsen, S.K., Due, A., Jordy, A.B., et al. Health effect of the New Nordic Diet in adults with increased waist circumference: A 6-mo randomized controlled trial. Am J Clin Nutr 99 (2014), 35–45.
172. Nordmann, A.J., Nordmann, A., Briel, M., et al. Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: A meta-analysis of randomized controlled trials. Arch Intern Med 166 (2006), 285–293.
173. Stern, L., Iqbal, N., Seshadri, P., et al. The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: One-year follow-up of a randomized trial. Ann Intern Med 140 (2004), 778–785.
174. Shai, I., Schwarzfuchs, D., Henkin, Y., et al. Weight Loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 359 (2008), 229–241.
175. Dansinger, M.L., Gleason, J.A., Griffith, J.L., et al. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: A randomized trial. JAMA 293 (2005), 43–53.
176. Sievenpiper, J.L., Kendall, C.W., Esfahani, A., et al. Effect of non-oil-seed pulses on glycaemic control: A systematic review and meta-analysis of randomised controlled experimental trials in people with and without diabetes. Diabetologia 52 (2009), 1479–1495.
177. Ha, V., Sievenpiper, J.L., de Souza, R.J., et al. Effect of dietary pulse intake on established therapeutic lipid targets for cardiovascular risk reduction: A systematic review and meta-analysis of randomized controlled trials. CMAJ 186 (2014), E252–E262.
178. Jayalath, V.H., de Souza, R.J., Sievenpiper, J.L., et al. Effect of dietary pulses on blood pressure: A systematic review and meta-analysis of controlled feeding trials. Am J Hypertens 27 (2014), 56–64.
179. Kim, S.J., de Souza, R.J., Choo, V.L., et al. Effects of dietary pulse consumption on body weight: A systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr 103 (2016), 1213–1223.
180. Hosseinpour-Niazi, S., Mirmiran, P., Hedayati, M., et al. Substitution of red meat with legumes in the therapeutic lifestyle change diet based on dietary advice improves cardiometabolic risk factors in overweight type 2 diabetes patients: A cross-over randomized clinical trial. Eur J Clin Nutr 69 (2015), 592–597.
181. Afshin, A., Micha, R., Khatibzadeh, S., et al. Consumption of nuts and legumes and risk of incident ischemic heart disease, stroke, and diabetes: A systematic review and meta-analysis. Am J Clin Nutr 100 (2014), 278–288.
182. Health Canada, Eating well with Canada's food guide. 2007, Health Products and Food Branch, Office of Nutrition and Promotion, Ottawa Report No.: Publication H39e166/1990E http://www.hc-sc.gc.ca/fn-an/food-guide-aliment/index-eng.php.
183. Moazen, S., Amani, R., Homayouni Rad, A., et al. Effects of freeze-dried strawberry supplementation on metabolic biomarkers of atherosclerosis in subjects with type 2 diabetes: A randomized double-blind controlled trial. Ann Nutr Metab 63 (2013), 256–264.
184. Hegde, S.V., Adhikari, P., Nandini, M., et al. Effect of daily supplementation of fruits on oxidative stress indices and glycaemic status in type 2 diabetes mellitus. Complement Ther Clin Pract 19 (2013), 97–100.
185. Imai, S., Matsuda, M., Hasegawa, G., et al. A simple meal plan of “eating vegetables before carbohydrate” was more effective for achieving glycemic control than an exchange-based meal plan in Japanese patients with type 2 diabetes. Asia Pac J Clin Nutr 20 (2011), 161–168.
186. Shin, J.Y., Kim, J.Y., Kang, H.T., et al. Effect of fruits and vegetables on metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials. Int J Food Sci Nutr 66 (2015), 416–425.
187. Petersen, K.S., Clifton, P.M., Blanch, N., et al. Effect of improving dietary quality on carotid intima media thickness in subjects with type 1 and type 2 diabetes: A 12-mo randomized controlled trial. Am J Clin Nutr 102 (2015), 771–779.
188. Viguiliouk, E., Kendall, C.W., Blanco Mejia, S., et al. Effect of tree nuts on glycemic control in diabetes: A systematic review and meta-analysis of randomized controlled dietary trials. Endocrinol Metab Clin North Am, 9, 2014, e103376.
189. Blanco Mejia, S., Kendall, C.W., Viguiliouk, E., et al. Effect of tree nuts on metabolic syndrome criteria: A systematic review and meta-analysis of randomised controlled trials. BMJ Open, 4, 2014, e004660.
190. Sabate, J., Oda, K., Ros, E., Nut consumption and blood lipid levels: A pooled analysis of 25 intervention trials. Arch Intern Med 170 (2010), 821–827.
191. Flores-Mateo, G., Rojas-Rueda, D., Basora, J., et al. Nut intake and adiposity: Meta-analysis of clinical trials. Am J Clin Nutr 97 (2013), 1346–1355.
192. Whole grains—get the facts, 2013, Health Canada, Ottawa http://www.hc-sc.gc.ca/fn-an/nutrition/whole-grain-entiers-eng.php.
193. Hollænder, P.L., Ross, A.B., Kristensen, M., Whole-grain and blood lipid changes in apparently healthy adults: A systematic review and meta-analysis of randomized controlled studies. Am J Clin Nutr 102 (2015), 556–572.
194. Bao, L., Cai, X., Xu, M., et al. Effect of oat intake on glycaemic control and insulin sensitivity: A meta-analysis of randomised controlled trials. Br J Nutr 112 (2014), 457–466.
195. Chen, M., Pan, A., Malik, V.S., et al. Effects of dairy intake on body weight and fat: A meta-analysis of randomized controlled trials. Am J Clin Nutr 96 (2012), 735–747.
196. Benatar, J.R., Sidhu, K., Stewart, R.A., Effects of high and low fat dairy food on cardio-metabolic risk factors: A meta-analysis of randomized studies. PLoS ONE, 8, 2013, e76480.
197. Maersk, M., Belza, A., Stødkilde-Jørgensen, H., et al. Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: A 6-mo randomized intervention study. Am J Clin Nutr 95 (2012), 283–289.
198. Maki, K.C., Nieman, K.M., Schild, A.L., et al. Sugar-wweetened product consumption alters glucose homeostasis compared with dairy product consumption in men and women at risk of type 2 diabetes mellitus. J Nutr 145 (2015), 459–466.
199. Alexander, D.D., Bylsma, L.C., Vargas, A.J., et al. Dairy consumption and CVD: A systematic review and meta-analysis—CORRIGENDUM. Br J Nutr, 115, 2016, 2268.
200. de Goede, J., Soedamah-Muthu, S.S., Pan, A., et al. Dairy consumption and risk of stroke: A systematic review and updated dose-response meta-analysis of prospective cohort studies. J Am Heart Assoc, 5, 2016 pii: e002787.
201. Wolever, T.M., Hamad, S., Chiasson, J.L., et al. Day-to-day consistency in amount and source of carbohydrate intake associated with improved blood glucose control in type 1 diabetes. J Am Coll Nutr 18 (1999), 242–247.
202. Clement, S., Diabetes self-management education. Diabetes Care 18 (1995), 1204–1214.
203. Savoca, M.R., Miller, C.K., Ludwig, D.A., Food habits are related to glycemic control among people with type 2 diabetes mellitus. J Am Diet Assoc 104 (2004), 560–566.
204. Kalergis, M., Schiffrin, A., Gougeon, R., et al. Impact of bedtime snack composition on prevention of nocturnal hypoglycemia in adults with type 1 diabetes undergoing intensive insulin management using lispro insulin before meals: A randomized, placebo-controlled, crossover trial. Diabetes Care 26 (2003), 9–15.
205. Arnold, L., Mann, J.I., Ball, M.J., Metabolic effects of alterations in meal frequency in type 2 diabetes. Diabetes Care 20 (1997), 1651–1654.
206. Leroux, C., Brazeau, A.S., Gingras, V., et al. Lifestyle and cardiometabolic risk in adults with type 1 diabetes: A review. Can J Diabetes 38 (2014), 62–69.
207. Delahanty, L.M., Nathan, D.M., Lachin, J.M., et al. Association of diet with glycated hemoglobin during intensive treatment of type 1 diabetes in the Diabetes Control and Complications Trial. Am J Clin Nutr 89 (2009), 518–524.
208. Bell, K.J., Smart, C.E., Steil, G.M., et al. Impact of fat, protein, and glycemic index on postprandial glucose control in type 1 diabetes: Implications for intensive diabetes management in the continuous glucose monitoring era. Diabetes Care 38 (2015), 1008–1015.
209. Marran, K.J., Davey, B., Lang, A., et al. Exponential increase in postprandial blood-glucose exposure with increasing carbohydrate loads using a linear carbohydrate-to-insulin ratio. S Afr Med J 103 (2013), 461–463.
210. International Diabetes Federation, DAR International Alliance, Diabetes and Ramadan: Practical guidelines. 2016, (IDF) IDF, Brussels http://www.daralliance.org/daralliance/wp-content/uploads/IDF-DAR-Practical-Guidelines_15-April-2016_low.pdf.
211. Tunbridge, F.K., Home, P.D., Murphy, M., et al. Does flexibility at mealtimes disturb blood glucose control on a multiple insulin injection regimen?. Diabet Med 8 (1991), 833–838.
212. DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: Dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ, 325, 2002, 746.
213. Scavone, G., Manto, A., Pitocco, D., et al. Effect of carbohydrate counting and medical nutritional therapy on glycaemic control in type 1 diabetic subjects: A pilot study. Diabet Med 27 (2010), 477–479.
214. Bergenstal, R.M., Johnson, M., Powers, M.A., et al. Adjust to target in type 2 diabetes: Comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine. Diabetes Care 31 (2008), 1305–1310.
215. Gillespie, S.J., Kulkarni, K.D., Daly, A.E., Using carbohydrate counting in diabetes clinical practice. J Am Diet Assoc 98 (1998), 897–905.
216. Kelley, D.E., Sugars and starch in the nutritional management of diabetes mellitus. Am J Clin Nutr 78 (2003), 858s–864s.
217. Rossi, M.C., Nicolucci, A., Di Bartolo, P., et al. Diabetes Interactive Diary: A new telemedicine system enabling flexible diet and insulin therapy while improving quality of life: An open-label, international, multicenter, randomized study. Diabetes Care 33 (2010), 109–115.
218. Huckvale, K., Adomaviciute, S., Prieto, J.T., et al. Smartphone apps for calculating insulin dose: A systematic assessment. BMC Med, 13(1), 2015.
219. List of permitted sweeteners (list of permitted food additives), 2016, Health Canada, Ottawa http://www.hc-sc.gc.ca/fn-an/securit/addit/list/archive-9-sweetener-edulcorant-2017-04-27-eng.php.
220. Gougeon, R., Spidel, M., Lee, K., et al. Canadian Diabetes Association National Nutrition Committee technical review: Nonnutritive intense sweeteners in diabetes management. Can J Diabetes, 28, 2004, 385*99.
221. Maki, K.C., Curry, L.L., Reeves, M.S., et al. Chronic consumption of rebaudioside A, a steviol glycoside, in men and women with type 2 diabetes mellitus. Food Chem Toxicol 46:Suppl. 7 (2008), S47–S53.
222. Barriocanal, L.A., Palacios, M., Benitez, G., et al. Apparent lack of pharmacological effect of steviol glycosides used as sweeteners in humans. A pilot study of repeated exposures in some normotensive and hypotensive individuals and in Type 1 and Type 2 diabetics. Regul Toxicol Pharmacol 51 (2008), 37–41.
223. Azad, N.A., Mielniczuk, L., A call for collaboration: Improving cardiogeriatric care. Can J Cardiol 32 (2016), 1041–1044.
224. Narain, A., Kwok, C.S., Mamas, M.A., Soft drinks and sweetened beverages and the risk of cardiovascular disease and mortality: A systematic review and meta-analysis. Int J Clin Pract 70 (2016), 791–805.
225. Rogers, P.J., Hogenkamp, P.S., de Graaf, C., et al. Does low-energy sweetener consumption affect energy intake and body weight? A systematic review, including meta-analyses, of the evidence from human and animal studies. Int J Obes (Lond) 40 (2016), 381–394.
226. Wang, Y.M., van Eys, J., Nutritional significance of fructose and sugar alcohols. Annu Rev Nutr 1 (1981), 437–475.
227. Wolever, T.M.S., Pickarz, A., Hollands, M., et al. Sugar alcohols and diabetes: A review. Can J Diabetes 26 (2002), 356–362.
228. Heymsfield, S.B., van Mierlo, C.A., van der Knaap, H.C., et al. Weight management using a meal replacement strategy: Meta and pooling analysis from six studies. Int J Obes Relat Metab Disord 27 (2003), 537–549.
229. Li, Z., Hong, K., Saltsman, P., et al. Long-term efficacy of soy-based meal replacements vs an individualized diet plan in obese type II DM patients: Relative effects on weight loss, metabolic parameters, and C-reactive protein. Eur J Clin Nutr 59 (2005), 411–418.
230. Cheskin, L.J., Mitchell, A.M., Jhaveri, A.D., et al. Efficacy of meal replacements versus a standard food-based diet for weight loss in type 2 diabetes: A controlled clinical trial. Diabetes Educ 34 (2008), 118–127.
231. Yip, I., Go, V.L., DeShields, S., et al. Liquid meal replacements and glycemic control in obese type 2 diabetes patients. Obes Res 9:Suppl. 4 (2001), 341s–347s.
232. McCargar, L.J., Innis, S.M., Bowron, E., et al. Effect of enteral nutritional products differing in carbohydrate and fat on indices of carbohydrate and lipid metabolism in patients with NIDDM. Mol Cell Biochem 188 (1998), 81–89.
233. Lansink, M., van Laere, K.M., Vendrig, L., et al. Lower postprandial glucose responses at baseline and after 4 weeks use of a diabetes-specific formula in diabetes type 2 patients. Diabetes Res Clin Pract 93 (2011), 421–429.
234. Stockwell, T., Zhao, J., Thomas, G., Should alcohol policies aim to reduce total alcohol consumption? New analyses of Canadian drinking patterns. Addict Res Theory 17 (2009), 135–151.
235. Butt, P., Beimess, D., Stockwell, T., et al. Alcohol and health in Canada: A summary of evidence and guidelines for low-risk drinking. 2011, Canadian Centre on Substance Abuse, Ottawa http://www.ccsa.ca/Resource%20Library/2011-Summary-of-Evidence-and-Guidelines-for-Low-Risk%20Drinking-en.pdf.
236. Blomster, J.I., Zoungas, S., Chalmers, J., et al. The relationship between alcohol consumption and vascular complications and mortality in individuals with type 2 diabetes. Diabetes Care 37 (2014), 1353–1359.
237. Ahmed, A.T., Karter, A.J., Warton, E.M., et al. The relationship between alcohol consumption and glycemic control among patients with diabetes: The Kaiser Permanente Northern California Diabetes Registry. J Gen Intern Med 23 (2008), 275–282.
238. Kerr, D., Macdonald, I.A., Heller, S.R., et al. Alcohol causes hypoglycaemic unawareness in healthy volunteers and patients with type 1 (insulin-dependent) diabetes. Diabetologia 33 (1990), 216–221.
239. Richardson, T., Weiss, M., Thomas, P., et al. Day after the night before: Influence of evening alcohol on risk of hypoglycemia in patients with type 1 diabetes. Diabetes Care 28 (2005), 1801–1802.
240. Cheyne, E.H., Sherwin, R.S., Lunt, M.J., et al. Influence of alcohol on cognitive performance during mild hypoglycaemia; implications for type 1 diabetes. Diabet Med 21 (2004), 230–237.
241. Pietraszek, A., Gregersen, S., Hermansen, K., Alcohol and type 2 diabetes. A review. Nutr Metab Cardiovasc Dis 20 (2010), 366–375.
242. Gallagher, A., Connolly, V., Kelly, W.F., Alcohol consumption in patients with diabetes mellitus. Diabet Med 18 (2001), 72–73.
243. Carter, S., Clifton, P.M., Keogh, J.B., The effects of intermittent compared to continuous energy restriction on glycaemic control in type 2 diabetes; a pragmatic pilot trial. Diabetes Res Clin Pract 122 (2016), 106–112.
244. Alabbood, M.H., Ho, K.W., Simons, M.R., The effect of Ramadan fasting on glycaemic control in insulin dependent diabetic patients: A literature review. Diabetes Metab Syndr 11 (2016), 83–87.
245. Chenhall, C., Healthy Living Issue Group (HLIG) of the Pan-Canadian Public Health Network. Improving cooking and food preparation skills. A synthesis paper of the evidence to inform program and policy development. 2010, Canada Go, Ottawa Report No.: Cat.: H164-123/1-2010E-PDF https://www.canada.ca/content/dam/hc-sc/migration/hc-sc/fn-an/alt_formats/pdf/nutrition/child-enfant/cfps-acc-synthes-eng.pdf.
246. Desjardins, E., Making something out of nothing: Food literacy among youth, young pregnant women and young parents who are at risk for poor health. 2013, Public Health Ontario, Toronto https://www.publichealthontario.ca/en/ServicesAndTools/Documents/LDCP/LDCP.Food.Skills_Report_WEB_FINAL.pdf.
247. Food skills: Definitions, influences and relationship with health, 2014, SafeFood (Food Safety Promotion Board), Cork, Ireland.
248. Slater, J., Is cooking dead? The state of home economics food and nutrition education in a Canadian province. Int J Consum Stud 37 (2013), 617–624.
249. Nelson, S.A., Corbin, M.A., Nickols-Richardson, S.M., A call for culinary skills education in childhood obesity-prevention interventions: Current status and peer influences. J Acad Nutr Diet 113 (2013), 1031–1036.
250. Moubarac, J.C., Batal, M., Martins, A.P., et al. Processed and ultra-processed food products: Consumption trends in Canada from 1938 to 2011. Can J Diet Pract Res 75 (2014), 15–21.
251. Kahleova, H., Matoulek, M., Malinska, H., et al. Vegetarian diet improves insulin resistance and oxidative stress markers more than conventional diet in subjects with Type 2 diabetes. Diabet Med 28 (2011), 549–559.
252. Moher, D., Liberati, A., Tetzlaff, J., et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med, 6, 2009, e1000097.